Pharmacological prevention of thrombotic occlusion in arterial reconstructive surgery.
D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000037:antagonists & inhibitors; D001157:Arterial Occlusive Diseases / Q000517:prevention & control*; D001241:Aspirin / Q000627:therapeutic use; D001792:Blood Platelets / Q000378:metabolism; D000242:Cyclic AMP / Q000097:blood; D003911:Dextrans / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D012306:Risk; D013917:Thrombin / Q000037:antagonists & inhibitors; D013927:Thrombosis / Q000517:prevention & control*; D014656:Vascular Surgical Procedures / Q000009:adverse effects*
D001095:Arachidonic Acids; D003911:Dextrans; D016718:Arachidonic Acid; D004176:Dipyridamole; D006493:Heparin; D000242:Cyclic AMP; D013917:Thrombin; D001241:Aspirin